Engineered nanostructural materials for application in cancer biology and medicine

Nanotechnology covers a wide variety of fields of research, including chemistry, physics, biology and medicine, with extensive applications in cancer, ranging from accurate, early detection of malignant lesions to minimizing metastasis. Continued development of cancer‐targeted therapy has promising advantages: maximizing the effectiveness of anticancer drugs while decreasing the harmful systemic effects; tumor destruction via heating that takes advantage of magnetic nanoparticles' size, magnetization and biocompatibility; novel drug‐delivery systems; and gene therapy functions to facilitate controlled drug loading and release inside the cytoplasm. These and other nanotechnology applications can contribute essential new knowledge in the fight against cancer. Copyright © 2011 John Wiley & Sons, Ltd.

[1]  Gary M Williams,et al.  Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. , 2008, Mutation research.

[2]  M. Morris,et al.  Peptide-based strategy for siRNA delivery into mammalian cells. , 2005, Methods in molecular biology.

[3]  Yi Li,et al.  Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells , 2010, Breast Cancer Research and Treatment.

[4]  L. Liu,et al.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[5]  John Miller,et al.  Beyond biotechnology: FDA regulation of nanomedicine. , 2003, The Columbia science and technology law review.

[6]  P. Sismondi,et al.  Adjuvant Chemotherapy with High-Dose Cyclophosphamide, Etoposide and Cisplatin Intensification without Progenitor Cell Support in Breast Cancer Patients with Ten or More Involved Nodes: 5-Year Results of a Pilot Trial , 2001, Oncology.

[7]  John C. Bischof,et al.  Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery , 2006, Molecular Cancer Therapeutics.

[8]  Dwight G Nishimura,et al.  FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents , 2006, Nature materials.

[9]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[10]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[11]  Xianglin L. Du,et al.  Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer , 2011, Medical oncology.

[12]  J. Ajani,et al.  Oral etoposide for patients with advanced adenocarcinoma of the pancreas , 2004, Investigational New Drugs.

[13]  Mark R Wiesner,et al.  Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. , 2006, Nano letters.

[14]  Tao Chen.  The Role of MicroRNA in Chemical Carcinogenesis , 2010, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[15]  A. P. Alivisatos,et al.  Less is more in medicine. , 2001, Scientific American.

[16]  B. Teicher.  Newer Cytotoxic Agents: Attacking Cancer Broadly , 2008, Clinical Cancer Research.

[17]  A. Ragusa,et al.  Nanoparticles as Nonviral Gene Delivery Vectors , 2007, IEEE Transactions on NanoBioscience.

[18]  Ji-Xin Cheng,et al.  Gold Nanorods Mediate Tumor Cell Death by Compromising Membrane Integrity , 2007, Advanced materials.

[19]  G. Hortobagyi,et al.  Current management of advanced breast cancer. , 1996, Seminars in oncology.

[20]  H. Choy,et al.  Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  M. Morris,et al.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.

[22]  Yang Xu,et al.  Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells , 2011, International journal of nanomedicine.

[23]  Wei Qian,et al.  The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy , 2007, Lasers in surgery and medicine.

[24]  Michael J Sailor,et al.  Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. , 2009, Cancer research.

[25]  D. Maysinger,et al.  Nanoparticles and cells: good companions and doomed partnerships. , 2007, Organic & biomolecular chemistry.

[26]  Baorui Liu,et al.  The antitumor effect of novel docetaxel-loaded thermosensitive micelles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  N. Osheroff,et al.  A Two-drug Model for Etoposide Action against Human Topoisomerase IIα* , 2003, The Journal of Biological Chemistry.

[28]  G. Murphy,et al.  Clinical highlights from the National Cancer Data Base, 1999 , 1999, CA: a cancer journal for clinicians.

[29]  A. P. Alivisatos,et al.  Less is more in medicine. , 2001, Scientific American.

[30]  R. Banerjee,et al.  Liposomes: Applications in Medicine , 2001, Journal of biomaterials applications.

[31]  F. Goñi,et al.  Lipids favoring inverted phase enhance the ability of aerolysin to permeabilize liposome bilayers. , 2000, Biochemistry.

[32]  Zhongping Chen,et al.  Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles. , 2009, Journal of biomedical optics.

[33]  J. West,et al.  Immunotargeted nanoshells for integrated cancer imaging and therapy. , 2005, Nano letters.

[34]  Enkeleda Dervishi,et al.  Nanophotothermolysis of multiple scattered cancer cells with carbon nanotubes guided by time-resolved infrared thermal imaging. , 2009, Journal of biomedical optics.

[35]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[36]  Vladimir P. Zharov,et al.  Photothermal detection of local thermal effects during selective nanophotothermolysis , 2003 .

[37]  A. Eggermont,et al.  TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. , 2006, The oncologist.

[38]  Michael J Sailor,et al.  Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery , 2009, Advanced materials.

[39]  É. Duguet,et al.  Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .

[40]  B. Pulliam,et al.  Design of nanoparticle-based dry powder pulmonary vaccines , 2007, Expert opinion on drug delivery.

[41]  M. Amiji,et al.  Nanoparticulate carriers for the treatment of coronary restenosis , 2007, International journal of nanomedicine.

[42]  Thomas Kelly,et al.  Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy , 2005, Lasers in surgery and medicine.

[43]  H. Dai,et al.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Yang Xu,et al.  Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines , 2010, Journal of applied toxicology : JAT.

[45]  Kevin G. Rice,et al.  Peptide-guided gene delivery , 2007, The AAPS Journal.

[46]  Xiaohua Huang,et al.  Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.

[47]  P. Forterre,et al.  Effects of the antitumor drug VP16 (etoposide) on the archaebacterial Halobacterium GRB 1.7 kb plasmid in vivo. , 1987, Nucleic acids research.

[48]  R. N. Brogden,et al.  Etoposide , 2012, Drugs.

[49]  James F Rusling,et al.  Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. , 2009, ACS nano.

[50]  Thomas Kelly,et al.  In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. , 2009, Nature nanotechnology.

[51]  M. Mehra,et al.  Chemotherapy‐Related Cardiomyopathy: All That Glitters Is Not Gold , 2003 .

[52]  P. Koistinen,et al.  p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death. , 2001, Leukemia research.

[53]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Prato,et al.  Functionalized carbon nanotubes in drug design and discovery. , 2008, Accounts of chemical research.

[55]  M. Fromm,et al.  Pharmacokinetics of intravenous etoposide in patients with breast cancer: influence of dose escalation and cyclophosphamide and doxorubicin coadministration , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[56]  S. Nie,et al.  Quantum dot nanocrystals for in vivo molecular and cellular imaging. , 2004, Photochemistry and photobiology.

[57]  V. Zharov,et al.  Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug. , 2009, Nanomedicine.

[58]  N. Monteiro-Riviere,et al.  Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. , 2007, Nano letters.

[59]  Xiaohua Huang,et al.  Peptide-conjugated gold nanorods for nuclear targeting. , 2007, Bioconjugate chemistry.

[60]  R. Streicher,et al.  Nanosurfaces and nanostructures for artificial orthopedic implants. , 2007, Nanomedicine.

[61]  D. Grandér,et al.  Activation of Bak, Bax, and BH3-only Proteins in the Apoptotic Response to Doxorubicin* , 2002, The Journal of Biological Chemistry.

[62]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[63]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[64]  Prashant K. Jain,et al.  Determination of the Minimum Temperature Required for Selective Photothermal Destruction of Cancer Cells with the Use of Immunotargeted Gold Nanoparticles , 2006, Photochemistry and photobiology.

[65]  Yang Xu,et al.  Carbon-covered magnetic nanomaterials and their application for the thermolysis of cancer cells , 2010, International journal of nanomedicine.

[66]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[67]  Hui Hu,et al.  Bone cell proliferation on carbon nanotubes. , 2006, Nano letters.

[68]  J. V. Von Roenn,et al.  Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  Lyndsay Harris,et al.  Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma , 2002, Cancer.

[70]  Karluss Thomas,et al.  Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[71]  H. Dai,et al.  Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.

[72]  Douglas A Christensen,et al.  Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Yen Wah Tong,et al.  Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. , 2009, Biomaterials.

[74]  M. Prato,et al.  Biomedical applications of functionalised carbon nanotubes. , 2005, Chemical communications.

[75]  V. Zharov,et al.  Cobalt nanoparticles coated with graphitic shells as localized radio frequency absorbers for cancer therapy , 2008, Nanotechnology.

[76]  Shelton D Caruthers,et al.  Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. , 2006, Nanomedicine.

[77]  C. Bailly,et al.  Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity. , 2000, Anti-cancer drug design.

[78]  Bernd Büchner,et al.  Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. , 2008, Nanomedicine.

[79]  K. Bhalla,et al.  The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. , 2000, Cancer research.

[80]  S. Mocellin,et al.  TNF and cancer: the two sides of the coin. , 2008, Frontiers in bioscience : a journal and virtual library.

[81]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[82]  S. Simões,et al.  Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[83]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[84]  Steven K. Gibb.  Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[85]  J. Dobson,et al.  Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.

[86]  Vladimir P Torchilin,et al.  Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[87]  J. Rosenecker,et al.  siRNA delivery by magnetofection. , 2008, Current opinion in molecular therapeutics.

[88]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[89]  M. Woodle,et al.  Harnessing in vivo siRNA delivery for drug discovery and therapeutic development , 2006, Drug Discovery Today.